 |
| SEPTEMBER
29, 2026 |
| Regional
intelligence on rugs, Diagnostics, Devices
& Digital Health |
|
|
|
* may need subscription to view |
|
BIG4BIO
CEO WEEKLY Q&A:
Kate Torchilin, Ph.D., M.B.A., CEO and
President, Mirai Bio |
| In
this CEO Q&A, Torchilin discusses the
delivery bottleneck that inspired Mirai's
founding, what differentiates its
integrated LNP platform, the milestone
that took a partner program from concept
to IND-enabling studies in under ten
months, and leading within the Flagship
Pioneering ecosystem. More |
|
|
 |
San
Diego: Meet & Greet | Oct 1
Get
priority access to Mispro’s New
Sorrento Mesa Contract Vivarium |
|
Learn More
→ |
|
|
- Acadia
Pharmaceuticals: Allowance of U.S. Patent
Covering Weight-Banded Dosing of
Trofinetide, extending U.S. Patent
Protections to March 2041 More
- Caspian
Therapeutics: Unveils KO-7246 at EASD as a
Potential Best-In-Class Menin Inhibitor for
Diabetes More
- Daré
Bioscience: New U.S. Patent Strengthening
DARE-HPV Program as a Potential First
FDA-Approved Pharmacologic Treatment for HPV
Infection More
- Oncolytics
Biotech: Accelerating Enrollment in Randomized
REO 033 RAS-Mutant, MSS Colorectal Cancer
Study More
|
|
 |
 |
|
Investment Banking Advisory to the
Life Science Industry |
|
Learn More
→ |
|
|
- More on ADARx's $446M IPO Signaling Investor
Appetite for Next-Gen RNA Therapeutics More
- More on MediciNova Drug Falling Short on
Liver Fat Parameter, Stock Tumbles More
- Reverse Mergers and SPACs – H1 2026 Review More
- Viking Therapeutics: Closing of Concurrent
Upsized Offerings of Common Stock and
Convertible Senior Notes, Including Full
Exercise of Underwriters' Options to Purchase
Additional Shares of Common Stock and
Convertible Senior Notes More
|
|
 |
| The
future of advanced therapies:
Explore challenges and
opportunities shaping patient
access, site-of-care expansion and
commercialization. |
| Access the
Report → |
|
|
- Big4Bio CEO Weekly Q&A: Kate
Torchilin, Ph.D., M.B.A., CEO and President,
Mirai Bio More
- Biotech
& Pharma Updates | September 28, 2026 More
- LJI: LEAD Day Panel | AI and Multi-Omnics
- Building a New Era of Autoimmune and
Chronic Disease Research Video
- LJI: Q&A - Haoyang Li on
Immunotherapeutic Breakthroughs,
Cutting-Edge Tech, and What He Wants to Give
the World More
- Subscribe to LifeSci Startup for
Updates on US Startups More
- The Biotech Startups Podcast: How Teaching
High School Prepares You to Run a Company Podcast
|
|
 |
 |
| Life
Sciences Talent and Consulting
Strategist George Quinn Named
Partner, Fractional Talent at
Slone Partners |
|
Learn More
→ |
|
|
- Avenzo Therapeutics: Expands Leadership Team
More
- Carlsmed: Appoints Richard Heppenstall as
Chief Financial Officer More
- CytoHub: Co-Founder Aitor Aguirre Named to
Lead Cardiac Tissue Engineering at NIH's First
National Organoid Center More
- ICYMI: Callio Therapeutics Appoints Chris
Hassig, PhD, as Chief Scientific Officer More
- ICYMI: Chutes & Ladders—Travere Chief
Makes Way for Former Amicus CEO More
- Neurocrine Biosciences: Appoints Eiry W.
Roberts, M.D., as Chief Medical Officer More
- OPPORTUNITY: Vice President, Business
Development, Remote More
- OPPORTUNITY: Director of Compliance, Remote
More
- Slone Partners: Beyond the Org Chart
- Redefining Leadership Roles After an
Acquisition More
|
|
 |
|
DISCOVER COMPANIES |
|
Big4Bio: San Diego Life Science
Company Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:San
Diego, all rights reserved
2026
© 2026
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
